ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results
To access this article, please choose from the options below
PII: S0041-1345(03)00679-1
doi:10.1016/S0041-1345(03)00679-1
© 2003 Elsevier Science Inc. All rights reserved.
